OMER: Insiders vs. Shorts
June 19, 2013
The most recent short interest data was recently released by the NASDAQ for the 05/31/2013 settlement date, and Omeros Corp (OMER) is one of the most shorted stocks of the Russell 3000, based on 19.70... Read More
category
Stocks
from Market News Video
Omeros (OMER) Approved to Commence OMS721 Phase 1
June 13, 2013
Omeros Obtains Regulatory Approval to Initiate Phase 1 Clinical Trial for Lead Antibody in MASP-2 Program
June 13, 2013
from PR Newswire
Commit To Buy Omeros Corp At $4, Earn 24.7% Annualized
June 03, 2013
Investors eyeing a purchase of Omeros Corp (OMER) shares, but cautious about paying the going market price of $5.22/share, might benefit from considering selling puts among the alternative strategies... Read More
category
Dividends
from Dividend Channel
Commit To Buy Omeros Corp At $4, Earn 24.7% Annualized
June 03, 2013
Investors eyeing a purchase of Omeros Corp (OMER) shares, but cautious about paying the going market price of $5.22/share, might benefit from considering selling puts among the alternative strategies... Read More
category
Stocks
from Market News Video
Omeros Reports Positive Results from OMS824 Positron Emission Tomography Clinical Trial
May 31, 2013
-- OMS824 Achieves High Target Occupancy without Causing Movement Disorders Seen with Other PDE10 Inhibitors -- Read More
from PR Newswire
Omeros (OMER) Files CTA in Europe for OMS721 Trials
May 28, 2013
from PR Newswire
from PR Newswire
Omeros to Present at Two Upcoming Conferences
May 22, 2013
from PR Newswire
Traders in Omeros Attributing Upside in Shares to Bullish Note from MLV & Co., Says Trend Higher 'Will Continue'
May 14, 2013
from PR Newswire
Short Interest Jumps 41.2% For OMER
May 10, 2013
The most recent short interest data has been released by the NASDAQ for the 04/30/2013 settlement date, which shows a 1,529,276 share increase in total short interest for Omeros Corp (OMER), to... Read More
category
Stocks
from Market News Video
from PR Newswire
from PR Newswire
Omeros Corp. (OMER) Reports In-Line Q1 EPS
May 09, 2013
Trading Radar for 05/09: priceline.com (PCLN), NVIDIA (NVDA), DISH Network (DISH), Dean Foods (DF) Report
May 08, 2013
Omeros Requests Fast Track Designation for OMS824 for the Treatment of Huntington's Disease
May 01, 2013
from PR Newswire
Omeros Ophthalmology Product OMS302 Granted Eligibility for European Centralized Review
April 30, 2013
from PR Newswire
Omeros Reports OMS302 Clinical Data Presented at the Annual ASCRS and ASOA Symposium and Congress
April 25, 2013
-- Data Show that OMS302 Maintains Pupil Size During Lens Replacement Surgery by Not Only Promoting Mydriasis but also by Preventing Miosis -- Read More
from PR Newswire
from PR Newswire
Omeros to Present Additional OMS302 Clinical Data at the Annual ASCRS and ASOA Symposium and Congress
April 19, 2013
from PR Newswire
WBB Pounds the Table on Omeros Following Orphan Drug Status, Maintains Strong Buy Rating, $20 Target
April 18, 2013
Stock Market XML and JSON Data API provided by FinancialContent Services, Inc.
Nasdaq quotes delayed at least 15 minutes, all others at least 20 minutes.
Markets are closed on certain holidays. Stock Market Holiday List
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.
Press Release Service provided by PRConnect.
Stock quotes supplied by Telekurs USA
Postage Rates Bots go here
Nasdaq quotes delayed at least 15 minutes, all others at least 20 minutes.
Markets are closed on certain holidays. Stock Market Holiday List
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.
Press Release Service provided by PRConnect.
Stock quotes supplied by Telekurs USA
Postage Rates Bots go here